Last reviewed · How we verify
NCT04548245: MEDiATE
Markers of Executive Attention Development in Preschoolers
trial testing EEG in Attention Deficit Disorder in 70 participants. Status unknown.
1 October 2023
Quick facts
| Lead sponsor | University Hospital, Caen |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 1 February 2021 |
| Primary completion | 1 October 2023 |
| Estimated completion | 1 October 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- EEG
Conditions studied
- Attention Deficit Disorder — all drugs for Attention Deficit Disorder →
Sponsor
University Hospital, Caen
Who can join
Adults 48 Months to 60 Months, any sex, with Attention Deficit Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to identify precursors of executive attention that can serve as early markers of ADD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04548245
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of EEG
Trials testing the same drug.
- NCT04692922 — Prognostication of Recovery in Early Disorders of Consciousness Study · not yet recruiting
- NCT07149974 — Neurofeedback Training for Autistic Children · NA · enrolling by invitation
- NCT06867289 — Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring · NA · recruiting
- NCT06185257 — Electroencephalographic Changes in Nonconvulsive Children With Chronic Renal Disease · not yet recruiting
- NCT06449794 — Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital · recruiting
Other recruiting trials for Attention Deficit Disorder
Currently open trials in the same condition.
- NCT06248229 — A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder · Phase 4 · recruiting
- NCT06194162 — Weighted Blankets for Sleep Disturbance Among Children With ADHD · NA · recruiting
Other University Hospital, Caen trials
Trials by the same sponsor.
- NCT07406737 — Feasibility and Outcomes Registry of Lumenless dEfibrillation Leads for Conduction System Pacing · not yet recruiting
- NCT06639750 — Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion · not yet recruiting
- NCT07467031 — Bachstim Registry: a Feasability Study of Bachmann's Area Pacing · not yet recruiting
- NCT07477132 — A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 · Phase 4 · not yet recruiting
- NCT07520578 — EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WI · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04548245 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Caen
- Last refreshed: 13 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04548245.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing